Indonesia Year 1 Quarterly Report April 2011-June 2011

The project began in 2011 and was led by KNCV, with collaborating partners including ATS, FHI, MSH, The Union, and WHO. The project's overall work plan completion was 25% as of June 2011. During the third quarter of 2011, significant achievements were made in various technical areas. In Universal and Early Access, TB CARE I supported a project to engage pulmonologists in DOTS, resulting in the diagnosis of 1,049 TB patients. The project also facilitated a workshop on DOTS Hospital Accreditation, developing a draft standard/guideline for hospitals. In Laboratories, TB CARE I supported the renovation of two labs in Jayapura and Semarang, which were completed in June 2011. The project also provided technical assistance to 12 labs on smear microscopy quality assurance. Additionally, TB CARE I supported the implementation of GeneXpert, a new diagnostic tool, in 13 health facilities. In Infection Control, TB CARE I renovated four health centers in Solo, which were completed in June 2011. The project also conducted TB infection control assessments in several prisons and health facilities, with a plan to implement international standards. The project faced technical and administrative challenges, including delayed recruitment and approval for new sub-agreements. However, the overall project implementation was speeding up after receiving official approval in June 2011. The project aimed to continue and scale up its activities, including engaging 50 more pulmonologists and training laboratory technicians in new diagnostic tools. In terms of outcomes, the project reported significant progress in several areas. In Universal and Early Access, the number of MDR cases diagnosed increased to 392, and 272 cases were put on treatment. In Laboratories, the number of quality-assured laboratories for smear microscopy increased to 60%. In Infection Control, the number of health facilities implementing minimal TB IC packages increased to 10. The project's quarterly technical outcome report highlighted several challenges and next steps to reach its targets. In Universal and Early Access, the project aimed to strengthen the lab network and quality assurance for smear microscopy labs. In Laboratories, the project aimed to implement new diagnostic tools, including GeneXpert, and integrate them into the lab network. In Infection Control, the project aimed to improve TB-IC in PMDT sites and specific settings. Overall, the TB CARE I project in Indonesia made significant progress in improving TB diagnosis, treatment, and prevention services. However, the project faced several challenges and next steps were identified to reach its targets.